Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Cohen

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
JMIR Formative Research|June 26, 2024
The Feasibility and Acceptability of Sharing Video Recordings of Amyotrophic Lateral Sclerosis Clinical Encounters With Patients and Their Caregivers: Pilot Randomized Clinical TrialReed W R Bratches, Jeffrey Cohen, Elizabeth Carpenter-Song, et al.
BJU International|March 6, 2010
Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?Matthew Tollefson, James Magera, Thomas Sebo, et al.
JAMA Dermatology|May 15, 2026
Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway VariantsWilliam Liu, Angela J Luo, Winston Liu, et al.
Research Square|April 8, 2025
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosusVikram Shaw, Jinyoung Byun, Catherine Zhu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2014
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosisFrederik Barkhof, Remko de Jong, Nikolaos Sfikas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
MSJ-ETC EditorialJeffrey Cohen, Ho Jin Kim, Mar Tintore, et al.
Multiple Sclerosis and Related Disorders|September 27, 2019
Early initiation of fingolimod reduces the rate of severe relapses over the long term: Post hoc analysis from the FREEDOMS, FREEDOMS II, and TRANSFORMS studiesJudith Haas, Douglas Jeffery, Diego Silva, et al.
Archives of Pathology & Laboratory Medicine|September 7, 2021
Early Antibody Temporal Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Vaccinated Subjects Determined by the cobas 6000 Spike AssayHanna S Loving, Paulina Stallcup, Peter Burbelo, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case ReportTracy Espiritu McKay, Matina Balou, Daniel J Kao, et al.
JAMA|December 12, 2018
Childbearing and Family Leave Policies for Resident Physicians at Top Training InstitutionsKirti Magudia, Alexander Bick, Jeffrey Cohen, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
JMIR Formative Research|June 26, 2024
The Feasibility and Acceptability of Sharing Video Recordings of Amyotrophic Lateral Sclerosis Clinical Encounters With Patients and Their Caregivers: Pilot Randomized Clinical TrialReed W R Bratches, Jeffrey Cohen, Elizabeth Carpenter-Song, et al.
BJU International|March 6, 2010
Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?Matthew Tollefson, James Magera, Thomas Sebo, et al.
JAMA Dermatology|May 15, 2026
Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway VariantsWilliam Liu, Angela J Luo, Winston Liu, et al.
Research Square|April 8, 2025
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosusVikram Shaw, Jinyoung Byun, Catherine Zhu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2014
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosisFrederik Barkhof, Remko de Jong, Nikolaos Sfikas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
MSJ-ETC EditorialJeffrey Cohen, Ho Jin Kim, Mar Tintore, et al.
Multiple Sclerosis and Related Disorders|September 27, 2019
Early initiation of fingolimod reduces the rate of severe relapses over the long term: Post hoc analysis from the FREEDOMS, FREEDOMS II, and TRANSFORMS studiesJudith Haas, Douglas Jeffery, Diego Silva, et al.
Archives of Pathology & Laboratory Medicine|September 7, 2021
Early Antibody Temporal Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Vaccinated Subjects Determined by the cobas 6000 Spike AssayHanna S Loving, Paulina Stallcup, Peter Burbelo, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 71 New Frontiers: Inpatient Comprehensive Rehabilitation After Full Face Transplantation: A Case ReportTracy Espiritu McKay, Matina Balou, Daniel J Kao, et al.
JAMA|December 12, 2018
Childbearing and Family Leave Policies for Resident Physicians at Top Training InstitutionsKirti Magudia, Alexander Bick, Jeffrey Cohen, et al.
Pageof 12